PPP2CA and breast carcinoma: This is mainly because miR-183-5p, which inhibits the expression of PPP2CA, can be transferred from breast cancer cells to macrophages through exosomes, thus, promoting the secretion of proinflammatory cytokines and contributing to tumor progression in breast cancer.